The 11th Annual AMR Conference 2027 is a leading European conference dedicated to novel antimicrobials, antimicrobial resistance, and AMR diagnostics. The event brings together scientists, clinicians, biotechnology and pharmaceutical companies, diagnostics developers, investors, researchers, policymakers, and other experts working to address the growing global threat of antimicrobial resistance.

The conference focuses on accelerating the development of new antibiotics, alternative antimicrobial approaches, rapid diagnostics, and innovative solutions for drug-resistant infections. It provides a platform for translating scientific discoveries into clinical and commercial applications.

Key topics include antimicrobial resistance, novel antibiotics, antimicrobial drug discovery, AMR diagnostics, rapid pathogen detection, antimicrobial stewardship, precision infectious disease treatment, clinical development, regulatory pathways, biotechnology, financing, and commercialization.

A major strength of the AMR Conference 2027 is its combination of scientific and industry perspectives. Participants can explore the latest developments in antimicrobial research while also discussing drug development, investment, regulatory challenges, partnerships, and strategies for bringing new AMR solutions to patients.

The conference is particularly relevant to pharmaceutical and biotechnology companies, academic researchers, clinical specialists, diagnostic companies, investors, policymakers, and startups working in infectious diseases and antimicrobial innovation.